anti-PD1 treatmentimmune checkpoint therapyTNG260pembrolizumab
…t CoREST inhibition by TNG260 sensitizes STK11-mutant tumors to anti-PD1 treatment. TNG260, in combination with pembrolizumab, is being evaluated …
2articles mentioning treatments
2treatment mentions
1distinct treatments extracted
0%of mentions human-reviewed
Active filtersEntity: immune checkpoint therapy ×
immune checkpoint therapy
This treatment is selected. Its supporting articles are shown below.
Articles mentioning immune checkpoint therapy
2 articles · page 1 of 1anti-programmed cell death protein-1 therapyimmune checkpoint therapynasopharyngeal carcinomaN4-acetylcytidineNPC
…thereby facilitating tumor immune evasion and the resistance to anti-programmed cell death protein-1 therapy. This commentary evaluates the significance of these findings w…